Palmitoylethanolamide and other Lipid Autacoids in the Treatment of Chronic Pain: A New Chapter in Pain Medicine

  • Mical Pysio
  • Published 2016

Abstract

We gathered clinical experience since 2010 using an oral formulation of an endogenous lipid messenger, an autacoid, in a great many neuropathic pain disorders [1]. This compound palmitoylethanolamide (PEA), is the prototype of lipid autacoids, able to counteract chronic inflammation and chronic pain. PEA is available since 2005 as a supplement… (More)

Topics

1 Figure or Table

Cite this paper

@inproceedings{Pysio2016PalmitoylethanolamideAO, title={Palmitoylethanolamide and other Lipid Autacoids in the Treatment of Chronic Pain: A New Chapter in Pain Medicine}, author={Mical Pysio}, year={2016} }